Business

FTC Accuses Drug Middlemen of Driving Up Insulin Prices




The Federal Trade Commission has sued drug middlemen that health insurance plans use to control drug spending, accusing the companies of inflating insulin prices.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *